SPDR S&P BIOTECH ETF (XBI)
US78464A8707 - ETF
XBI June 7th Options Begin Trading
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.
5 Healthcare Stocks to Buy for 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
3 Top ETFs I Plan to Buy in April
These ETFs are easy, low-cost ways to invest in certain themes.
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
3 Biotech ETFs Overdue for a Bounce
The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
The company reported in-line sales for the fourth quarter, but shares soared by double digits.
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
2023 in Review: Key Stock Trends and Sector Shifts Unveiled
Investors would be smart to pay attention to these stock trends, many of which are taking hold as the New Year begins.
Biogen, Neurocrine, and more are Bairds top picks for biotech in 2024 (NYSEARCA:XBI)
Biotechnology (XBI) is set to outperform this year thanks to monetary policy easing, according to a Baird Equity Research Morning Report, published on Thursday.
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024
These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.
3 Thematic Growth ETFs to Load Up on Right Now
These three thematic ETFs could be potent growth vehicles in years to come.
Can Moderna stock rebound in 2024? (NASDAQ:MRNA)
Moderna (MRNA) experienced a significant decline in stock performance in 2023 as demand for its COVID-19 vaccine dropped. What's in store for the biotech in 2024.
Novavax stock in 2024: What to expect? (NASDAQ:NVAX)
Novavax (NVAX) like other COVID-19 vaccine makers has sold off in 2023. Read what to expect from the maker of Nuvaxovid vaccine in 2024.
Absci stock gains as AI drug discovery rallies (NASDAQ:ABSI)
Absci Corporation (ABSI) reaches new highs as AI-led drug development gains momentum, fueled by deals with industry leaders like Nvidia (NVDA). Read more here.